Press Release | Newsroom | Medtronic | Covidien Announces Investor Meeting Agenda

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Covidien Announces Investor Meeting Agenda

DUBLIN--(BUSINESS WIRE)--Aug. 30, 2012-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Thursday, September 13, 2012. The event will be held at Cipriani, 55 Wall Street, New York, NY. A webcast of the presentations will begin at 1:40 pm ET and the webcast will conclude by 5:00 pm ET.

The program will include presentations by Covidien's Chairman, President and Chief Executive Officer José (Joe) E. Almeida and Chief Financial Officer Charles J. Dockendorff, as well as Q&A with members of the senior management team. For those investors who are unable to attend the meeting in person, but who would like to ask a question of the management team during the meeting, questions can be emailed to


    11:00 a.m.       Registration Opens; Product Displays; Senior Management Reception
1:40 p.m. Formal program begins


José (Joe) E. Almeida, Chairman, President and CEO

Healthcare Reform / Reimbursement Panel Discussion – Moderated by Dr. Michael Tarnoff, Covidien Corporate Chief Medical Officer

Q&A with Senior Management Team

4:10 p.m. Charles J. Dockendorff, Chief Financial Officer
4:30 p.m. Financial Q&A
5:00 p.m. Presentations and webcast end

Advance registration is required to attend in person and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website:

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien’s website: A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.


Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 43,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit to learn more about our business.

Source: Covidien

Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
Bruce Farmer, 508-452-4372
Vice President
Public Relations
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
Todd Carpenter, 508-452-4363
Investor Relations